Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction

NCT04210180 is registered in ClinicalTrials.gov with Rose Research Center, LLC as lead sponsor.

NCT NCT04210180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04210180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction
Lead sponsor
Rose Research Center, LLC
Phase
Phase 2/3
Overall status
Completed
Start date
November 19, 2019
Completion date
March 22, 2021
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

harm reduction, smoking cessation